Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

751 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD study.
Van Mieghem NM, Windecker S, Manoharan G, Bosmans J, Bleiziffer S, Modine T, Linke A, Scholtz W, Tchétché D, Finkelstein A, Ito S, Eisenberg R, Grube E. Van Mieghem NM, et al. Among authors: finkelstein a. Catheter Cardiovasc Interv. 2022 Jan 1;99(1):171-178. doi: 10.1002/ccd.29889. Epub 2021 Jul 31. Catheter Cardiovasc Interv. 2022. PMID: 34331844 Free PMC article.
Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction.
Rozenman Y, Mehran R, Witzenbichler B, Dangas G, Desaga M, Kochman J, Nilsen DW, Finkelstein A, Mosseri M, Stone GW. Rozenman Y, et al. Among authors: finkelstein a. Catheter Cardiovasc Interv. 2013 Jan 1;81(1):E9-14. doi: 10.1002/ccd.24279. Epub 2012 Apr 17. Catheter Cardiovasc Interv. 2013. PMID: 22511592 Clinical Trial.
Radiation dose of patients undergoing transcatheter aortic valve implantation: a comparison between Edwards SAPIEN XT and Medtronic CoreValve aortic valve prostheses.
Steinvil A, Aviram G, Konigstein M, Abramowitz Y, Halkin A, Arbel Y, Ben-Gal Y, Keren G, Banai S, Finkelstein A. Steinvil A, et al. Among authors: finkelstein a. Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E578-82. doi: 10.1002/ccd.24951. Epub 2013 May 9. Catheter Cardiovasc Interv. 2013. PMID: 23592438
Predictors of high-risk angiographic findings in patients with non-ST-segment elevation acute coronary syndrome.
Beigel R, Matetzky S, Gavrielov-Yusim N, Fefer P, Gottlieb S, Zahger D, Atar S, Finkelstein A, Roguin A, Goldenberg I, Kornowski R, Segev A; ACSIS and ACSIS-PCI 2010 Investigators. Beigel R, et al. Among authors: finkelstein a. Catheter Cardiovasc Interv. 2014 Apr 1;83(5):677-83. doi: 10.1002/ccd.25081. Epub 2013 Nov 13. Catheter Cardiovasc Interv. 2014. PMID: 23784997
Outcome of transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction.
Biner S, Birati EY, Topilsky Y, Steinvil A, Ben Assa E, Sadeh B, Arbel Y, Halkin A, Abramowitz Y, Leshem-Rubinow E, Banai S, Keren G, Finkelstein A. Biner S, et al. Among authors: finkelstein a. Am J Cardiol. 2014 Jan 15;113(2):348-54. doi: 10.1016/j.amjcard.2013.08.048. Epub 2013 Oct 3. Am J Cardiol. 2014. PMID: 24210335
751 results